0001453687-20-000021.txt : 20200303
0001453687-20-000021.hdr.sgml : 20200303
20200303162544
ACCESSION NUMBER: 0001453687-20-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200301
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brunn Carsten
CENTRAL INDEX KEY: 0001760229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 20682649
MAIL ADDRESS:
STREET 1: C/O SELECTA BIOSCIENCES, INC.
STREET 2: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
wf-form4_158327072572666.xml
FORM 4
X0306
4
2020-03-01
0
0001453687
SELECTA BIOSCIENCES INC
SELB
0001760229
Brunn Carsten
C/O SELECTA BIOSCIENCES, INC.
480 ARSENAL WAY
WATERTOWN
MA
02472
1
1
0
0
President and CEO
Common Stock
2020-03-01
4
M
0
10937
0
A
81851
D
Common Stock
2020-03-03
4
S
0
3374
3.8564
D
78477
D
Restricted Stock Units
2020-03-01
4
M
0
10937
0
D
Common Stock
10937.0
120313
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.85 to $3.87. The Reporting Person undertakes to provide upon request to theSEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This restricted stock unit vests as to 25% on December 1, 2019. The remainder of the units will vest in twelve substantially equal quarterly installments thereafter. The restricted stock units have no expiration date.
/s/ Matthew Bartholomae, Attorney-in-Fact for Carsten Brunn
2020-03-03